Pierre‐François Laterre

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

Gordon R. Bernard, Jean‐Louis Vincent, Pierre‐François Laterre et al. · New England Journal of Medicine · 2001 · 6.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Hydrocortisone Therapy for Patients with Septic Shock

Charles L. Sprung, Djillali Annane, Didier Keh et al. · New England Journal of Medicine · 2008 · 2.1K citations · Full text

Medicine, Pharmacotherapy, Critical Care Pharmacotherapy +14

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

Edward Abraham, Pierre‐François Laterre, Rekha Garg et al. · New England Journal of Medicine · 2005 · 890 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis

Steven M. Opal, Pierre‐François Laterre, Bruno François et al. · JAMA · 2013 · 795 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +11

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

Roger G. Spragg, James F. Lewis, Hans‐Dieter Walmrath et al. · New England Journal of Medicine · 2004 · 419 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17